Israel Englander’s Pulmonx LUNG Stock Holding History

Israel Englander’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$656K	–	6366
2023 Q2	$656K	Buy	+50,000	New	+$612K	﹤0.01%	4350
2022 Q3	–	Sell	-100,000	Closed	-$1.47M	–	7325
2022 Q2	$1.47M	Buy	100,000 +50,000	+100%	+$1.03M	﹤0.01%	4009
2022 Q1	$1.24M	Buy	50,000 +30,000	+150%	+$775K	﹤0.01%	4329
2021 Q4	$641K	Buy	+20,000	New	+$730K	﹤0.01%	4828
2021 Q3	–	Sell	-10,000	Closed	-$441K	–	7062
2021 Q2	$441K	Sell	10,000 -7,900	-44%	-$344K	﹤0.01%	5407
2021 Q1	$819K	Buy	+17,900	New	+$1.03M	﹤0.01%	4399

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Israel Englander's LUNG Position: Q2 2026 in Review

Israel Englander opened a new position in Pulmonx (LUNG) in Q2 2026: 209,556 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #5161 among its holdings. This is a return to the name: Israel Englander previously reported a position in LUNG as recently as Q4 2025.

Israel Englander first reported a position in LUNG in Q1 2021 and has held it in 17 quarters since. The position peaked at $14.7M in Q1 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Israel Englander held 209,556 shares of Pulmonx worth $272K as of Q2 2026.
Pulmonx was a new Israel Englander position in Q2 2026.
Pulmonx made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5161 holding.
Israel Englander first reported a position in Pulmonx in Q1 2021 and has held it in 17 quarters since.
Israel Englander's Pulmonx position peaked at $14.7M in Q1 2021.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.